First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - RELYBO PHARMACHEMICAL COMPANY LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: RELYBO PHARMACHEMICAL COMPANY LIMITED, FOURTH FLOOR, 3 GOWER STREET, LONDON, WC1E 6HA. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 30 September 2018. The company was incorporated on 28 September 2010.

The accounts next due date is 30 June 2020. There are no mortgages.

The above was based on public record information as at 5 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 07388962
Date Incorporated: 28 September 2010
Date Latest Accounts: 30 September 2018
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 07388962
Annual Return: 10 September 2015
Registered Office: FOURTH FLOOR, 3 GOWER STREET, LONDON, WC1E 6HA
SIC Code and Operations: 99999
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

RELYBO PHARMACHEMICAL COMPANY LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 15 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
11623250 RELYCARE WEYMOUTH LTD Active
14833053 RELYCC LTD Active - Proposal to Strike off
13498123 RELYCLEANING LTD Active
08746583 RELYCO LTD Active - Proposal to Strike off
07328357 RELYCOMPUTERS [DOT] COM LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd